Further, it is tempting to speculate that therapeutic prevention of PDE6D down-regulation and/or PDE6D overexpression in animal models of pulmonary fibrosis may be beneficial to boost up alveolar re-epithelization and may represent a therapeutic option in IPF. Here, PDE6D is linked to pulmonary fibrosis.